Trial
NCT00642616
Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
Mannkind Corporation
Collaborators
—
Condition
Type 1 Diabetes Mellitus
Intervention
Technosphere® Insulin
Why stopped
Terminated upon recommendation of the Data Safety Monitoring Board (DSMB)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-14